Regular weight monitoring and nutritional assessment are essential
Side effects of weight loss drugs Four of the more popular GLP-1 medications Ozempic and Mounjaro (approved for diabetes) and Wegovy and Zepbound (approved for weight loss, plus a few other conditions) have similar side effects
Ueda S, Yamagishi SI, Matsumoto Y, Fukami K, Okuda S (2007) Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease
[1] [5] Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Vitamin C: Gim np nhn, gim nm da, lm sng da, chng nng